Showing results (51-60 of 540) with videos related to
Sort By:
Pageof 54
Current Opinion in HIV and AIDS|May 31, 2013
Sieve analysis in HIV-1 vaccine efficacy trialsPaul T Edlefsen, Peter B Gilbert, Morgane RollandBiostatistics (Oxford, England)|August 21, 2007
The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacyPeter B Gilbert, Ian W McKeague, Yanqing SunStatistics in Medicine|April 3, 2016
Power/sample size calculations for assessing correlates of risk in clinical efficacy trialsPeter B Gilbert, Holly E Janes, Yunda HuangCurrent Opinion in HIV and AIDS|September 24, 2016
Modeling HIV vaccine trials of the futurePeter B Gilbert, Ying Huang, Holly E JanesLifetime Data Analysis|May 8, 2004
Tests for comparing mark-specific hazards and cumulative incidence functionsPeter B Gilbert, Ian W McKeague, Yanqing SunStatistics in Medicine|November 6, 2007
Evaluating a surrogate endpoint at three levels, with application to vaccine developmentPeter B Gilbert, Li Qin, Steven G SelfMedrxiv : the Preprint Server for Health Sciences|January 27, 2021
Evaluating the Long-Term Efficacy of COVID-19 VaccinesDan-Yu Lin, Donglin Zeng, Peter B GilbertBiometrics|July 5, 2007
Genome scanning tests for comparing amino acid sequences between groupsPeter B Gilbert, Chunyuan Wu, David V JobesJournal of the American Statistical Association|January 6, 2009
Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected PostrandomizationBryan E Shepherd, Peter B Gilbert, Thomas LumleyBiometrics|September 21, 2006
A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trialDevan V Mehrotra, Xiaoming Li, Peter B GilbertPageof 54